EMA approves GSK’s COVID-19 treatment

The European Medicines Agency (EMA) authorized on Thursday the use of the monoclonal antibody Xevudy (sotrovimab) for the treatment of COVID-19 in people aged 12 and over, who are at risk of serious i…